2025. Impact of GLP-1 Receptor Agonists on Cardiovascular Risk Reduction in Patients with Type 2 Diabetes. Journal of Carcinogenesis. 24, 10s (Nov. 2025), 141–153. DOI:https://doi.org/10.64149/.